WO2004053081A3 - Compositions, splice variants and methods relating to prostate specific genes and proteins - Google Patents
Compositions, splice variants and methods relating to prostate specific genes and proteins Download PDFInfo
- Publication number
- WO2004053081A3 WO2004053081A3 PCT/US2003/038877 US0338877W WO2004053081A3 WO 2004053081 A3 WO2004053081 A3 WO 2004053081A3 US 0338877 W US0338877 W US 0338877W WO 2004053081 A3 WO2004053081 A3 WO 2004053081A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- compositions
- prostate
- antagonists
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered prostate tissue for treatment and research.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003297703A AU2003297703A1 (en) | 2002-12-06 | 2003-12-08 | Compositions, splice variants and methods relating to prostate specific genes and proteins |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43149102P | 2002-12-06 | 2002-12-06 | |
| US60/431,491 | 2002-12-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2004053081A2 WO2004053081A2 (en) | 2004-06-24 |
| WO2004053081A3 true WO2004053081A3 (en) | 2006-07-27 |
Family
ID=32507735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2003/038877 WO2004053081A2 (en) | 2002-12-06 | 2003-12-08 | Compositions, splice variants and methods relating to prostate specific genes and proteins |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003297703A1 (en) |
| WO (1) | WO2004053081A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003297703A1 (en) * | 2002-12-06 | 2004-06-30 | Diadexus, Inc. | Compositions, splice variants and methods relating to prostate specific genes and proteins |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004053081A2 (en) * | 2002-12-06 | 2004-06-24 | Diadexus, Inc. | Compositions, splice variants and methods relating to prostate specific genes and proteins |
-
2003
- 2003-12-08 AU AU2003297703A patent/AU2003297703A1/en not_active Abandoned
- 2003-12-08 WO PCT/US2003/038877 patent/WO2004053081A2/en not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004053081A2 (en) * | 2002-12-06 | 2004-06-24 | Diadexus, Inc. | Compositions, splice variants and methods relating to prostate specific genes and proteins |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003297703A1 (en) | 2004-06-30 |
| WO2004053081A2 (en) | 2004-06-24 |
| AU2003297703A8 (en) | 2004-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004053079A3 (en) | Compositions, splice variants and methods relating to ovarian specific genes and proteins | |
| WO2004092338A3 (en) | Compositions, splice variants and methods relating to cancer specific genes and proteins | |
| WO2002062945A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2002055735A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
| WO2002064741A3 (en) | Compositions and methods relating to breast specific genes and proteins | |
| WO2002040673A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2004050860A3 (en) | Compositions, splice variants and methods relating to colon specific genes and proteins | |
| WO2004053075A3 (en) | Compositions, splice variants and methods relating to breast specific genes and proteins | |
| WO2005017102A3 (en) | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins | |
| WO2004013311A3 (en) | Compositions and methods relating to ovarian specific genes and proteins | |
| WO2003106648A3 (en) | Compositions and methods relating to breast specific genes and proteins | |
| WO2004050858A3 (en) | Compositions, splice variants and methods relating to colon specific genes and proteins | |
| WO2002042463A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
| WO2002064788A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2003066877A3 (en) | Compositions and methods relating to hepatic specific genes and proteins | |
| WO2004052290A3 (en) | Compositions, splice variants and methods relating to breast specific genes and proteins | |
| WO2004053077A3 (en) | Compositions,splice variants and methods relating to breast specific genes and proteins | |
| WO2002042776A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
| WO2002039431A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
| WO2003020953A3 (en) | Compositions and methods relating to colon specific genes and proteins | |
| WO2004053081A3 (en) | Compositions, splice variants and methods relating to prostate specific genes and proteins | |
| WO2003020899A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2003020901A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
| WO2002048370A3 (en) | Compositions and methods relating to colon specific genes and proteins | |
| WO2003060081A3 (en) | Compositions and methods relating to endometrial specific genes and proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |